Home / Video Playlist / Cyclopharm (ASX:CYC) is expecting FDA approval for Technegas by September 2023!

Cyclopharm (ASX:CYC) is expecting FDA approval for Technegas by September 2023!

Check out our interview with CEO James McBrayer (4 April 2023)
Related Videos
Register for the Conference